Log in
Enquire now
‌

US Patent 10398659 Adjuvant chemotherapy for anaplastic gliomas

Patent 10398659 was granted and assigned to Oklahoma Medical Research Foundation on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation
Date Filed
April 12, 2018
Date of Patent
September 3, 2019
Patent Applicant
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation
Patent Application Number
15951699
Patent Citations Received
‌
US Patent 11660280 Treatment of drug resistant gliomas
0
Patent Inventor Names
Robert A. Floyd
0
Rheal A. Towner
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10398659
Patent Primary Examiner
‌
Samira J Jean-Louis

Find more entities like US Patent 10398659 Adjuvant chemotherapy for anaplastic gliomas

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.